Some people have hailed SpudCells as the first synthetic life. Adamala is not one of them. SpudCells are “obviously not ...

Prostate cancer is often resistant to immunotherapy, which harnesses a person's immune system to recognize and destroy tumors ...

US FDA clears Atrium Therapeutics’ IND application for ATR 1072 to treat of PRKAG2 syndrome: San Diego Wednesday, July 15, 2026, 13:00 Hrs [IST] Atrium Therapeutics, Inc., a bio ...

Atrium Therapeutics expects to enrol the first participant by the end of 2026.

Diranersen Alzheimer's drug results from the Phase 2 CELIA study show that Biogen's tau-targeting antisense therapy ...

Atrium Therapeutics, Inc. (Nasdaq: RNA) (the "Company"), a biopharmaceutical company dedicated to delivering RNA therapeutics to the heart, announced today that the U.S. Food and Drug Administration ...

Engineered extracellular vesicles delivered full-length Duchenne muscular dystrophy messenger RNA to skeletal muscle in preclinical models, restoring dystrophin production without serious toxicity A ...

The new antibiotic screening system proposed by the authors of the study proved to be sensitive to both fidaxomicin and ...

A study has shown that aging disrupts gene transcription and RNA processing, reducing the expression of long neuronal genes ...

Dr. Kristina Nienhaus Medien und News Universität Bielefeld. Plants do not wait hours to respond to intense sunlight ...

Nadine and David Lipworth have devoted their lives to finding treatment that will restore the daughter they knew.

Trace Neuroscience, Inc., a biopharmaceutical company expanding the promise of genomic medicine for people living with neurodegenerative diseases, today announced the initiation of its global clinical ...